Entecavir (Baraclude) and pegylated interferon alfa-2a (Pegasys) – New treatment options in chronic hepatitis B in Poland Waldemar Halota, Małgorzata Pawłowska Medical Science Review - Hepatologia 2007; 7 25-28 aaICID: 485980
Article type: Review article
IC™ Value: 2.88
Abstract provided by Publisher
Authors present the results of studies confirmed that entecavir and pegylated interferon alfa-2a are the attractive treatment options in chronic hepatitis B. Recently both these drugs have been registered in Poland and included in Consensus of CHB Treatment.